Published Guidance, NICE advice and quality standards
Showing 1 to 3 of 3
Title | Reference number | Published | Last updated |
---|---|---|---|
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | ||
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | ||
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 |